Get Patent Opposition Report for Biontech Rna Pharmaceuticals

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Biontech Rna Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3319622Method For Producing Rna Molecule CompositionsCUREVACNov 12, 2020
EP3173092Rna Containing Composition For Treatment Of Tumor DiseasesCUREVACMar 26, 2020

Explore Biontech Rna Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3445850Oct 27, 2021Methods For Providing Single-Stranded Rna1
EP3473267Sep 8, 2021Individualized Vaccines For Cancer1
EP2714071Jul 10, 2019Individualized Vaccines For Cancer3